BRIEF-Edwards Lifesciences Reaffirms Strategy For Sustainable, Differentiated Growth At Annual Investor Conference

Reuters
Dec 04, 2025
BRIEF-Edwards Lifesciences Reaffirms <a href="https://laohu8.com/S/MSTR">Strategy</a> For Sustainable, Differentiated Growth At Annual Investor Conference

Dec 4 (Reuters) - Edwards Lifesciences Corp EW.N:

  • EDWARDS LIFESCIENCES REAFFIRMS STRATEGY FOR SUSTAINABLE, DIFFERENTIATED GROWTH AT ANNUAL INVESTOR CONFERENCE

  • REAFFIRMS 2025 SALES GROWTH GUIDANCE OF 9%-10%

  • : REAFFIRMING 2025 EPS OUTLOOK OF $2.56 TO $2.62

  • PROJECTS 2026 SALES GROWTH OF 8%-10%

  • OUTLOOK FY 2026 ADJUSTED LEVERAGED EPS OF $2.80 - $2.95

  • FY2025 EARNINGS PER SHARE VIEW $2.58, REVENUE VIEW $6.03 BILLION -- LSEG IBES DATA

  • FY2026 EARNINGS PER SHARE VIEW $2.85, REVENUE VIEW $6.62 BILLION -- LSEG IBES DATA

Source text: ID:nBw4HJSQNa

Further company coverage: EW.N

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10